Learn What Is Glutathione Good For
5-Amino-1MQ: Next-Generation NNMT Inhibitor for Metabolic Research
As an obesity medicine physician scientist who regularly cares for patients with complex inflammatory conditions, this study reinforces what many of us have suspected clinically that the benefits of GLP-1 receptor agonists extend well beyond blood sugar control and weight loss and may fundamentally alter the disease trajectory for some of our highest-risk patients. Stanford, who was not involved in this research, is an obesity medicine physician scientist, educator and policy maker at Massachusetts General Hospital and Harvard Medical School, both in Boston
First report of efficacy of the naturally occurring glycine transport inhibitor sarcosin in schizophrenia
I pulled the two FDA labels and lined up their most common reactions, the ones that showed up in at least 5% of people in the trials, alongside the serious warnings
This may be partly due to lower total antioxidant activity in these patients, particularly the decrease in SOD and CAT activities (24, 25)